According to a study published, sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes may prevent dementia, with higher advantages with prolonged treatment.
Patients with and without diabetes can benefit from sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are drugs that, among other things, reduce blood sugar levels and improve heart and kidney function.